Short answer: aspirin tends to cause more stomach lining irritation and ulcers than celecoxib or meloxicam. Celecoxib (a COX-2 inhibitor) has the lowest GI risk among the three, and meloxicam (a preferential COX-2 inhibitor) is in between.
Details:
- Why aspirin damages the stomach lining
- It nonselectively and irreversibly inhibits COX-1 (which helps protect the stomach) and COX-2.
- COX-1 inhibition reduces protective gastric prostaglandins, making the stomach more prone to ulcers and bleeding.
- It can also irritate the stomach lining directly (topical effect).
- Risk increases with higher doses, longer use, age, history of ulcers, and when combined with other NSAIDs, steroids, or anticoagulants. Even low-dose aspirin raises GI bleeding risk.
- Why celecoxib tends to be gentler on the stomach
- Celecoxib is selective for COX-2 and spares COX-1, so it preserves much of the stomach’s protective prostaglandins.
- As a result, the risk of ulcers and GI bleeding is generally lower than with aspirin or nonselective NSAIDs.
- However, it’s not zero risk, and risk increases with age, high doses, longer use, and when combined with aspirin or other risk factors.
- Where meloxicam fits
- Meloxicam is a “preferential” COX-2 inhibitor (more COX-2–biased than many NSAIDs, but not entirely COX-2 selective).
- This gives better GI protection than traditional nonselective NSAIDs and aspirin, but typically not as strong as celecoxib.
- GI risk is generally intermediate: lower than aspirin/nonselective NSAIDs but higher than celecoxib in many comparisons, and still depends on dose, duration, and patient risk factors.
Practical notes:
- If someone has a history of ulcers or GI bleeding, a COX-2 inhibitor like celecoxib (often with a PPI) is commonly considered to reduce GI risk.
- If aspirin is needed for cardiovascular protection, doctors may use lower GI-risk strategies (e.g., the lowest effective dose, sometimes adding a PPI, or using alternative regimens) and monitor closely.
- Always consider individual risk factors (age, prior ulcers, concurrent meds) and talk with a clinician to choose the safest option for your situation.
If you want, tell me about the context (dose, duration, age, history of ulcers, other meds) and I can tailor the comparison further.